EUVIMEDEUVIMED entdecken
Crossref

Ginsenoside Rb1 inhibits chronic stress-induced colorectal cancer via regulating glycolysis and β2-AR/CREB1 signaling pathway

Wang Yao, Dong-Ming Hua, Wen-Kai Wang, Zhao-Zhou Zhang, Yun-Feng Guan iD, Yan Wang iD

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgaf031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Wang Yao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Ginsenosides, Colorectal Neoplasms, Glycolysis, Receptors, Adrenergic, beta-2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the mechanism of ginsenoside Rb1 (G-Rb1) against colorectal cancer under chronic stress.

Methods

A chronic restraint stress (CRS) model and a colorectal cancer (CRC) subcutaneous xenograft model were established. Western blot analysis quantified β2-adrenergic receptor (β2-AR), cAMP response element-binding protein 1 (CREB1), and p-CREB1 expression. Additionally, glycolytic enzymes GLUT1, HK2, and PFKP were analyzed via Western blot and RT-qPCR, with glucose uptake, lactate, ATP, and stress hormone levels assessed by flow cytometry, kits, and ELISA. Key findings Compared to the control group, the stress group exhibited increased tumor volume and mass, along with elevated expression of β2-AR, p-CREB1, and upregulated expression levels of GLUT1, HK2, and PFKP. Additionally, glucose, lactate, and epinephrine levels were higher in the stress group. In comparison to the stress group, G-Rb1 treatment demonstrated reduced tumor volume and mass, decreased p-CREB1 expression, as well as downregulated protein and mRNA levels of GLUT1, HK2, and PFKP. Glucose, lactate, and epinephrine levels also showed a reduction in the G-Rb1-treated groups.

Conclusions

G-Rb1 suppresses the growth of colorectal cancer under chronic stress, potentially through downregulation of the β2-AR/CREB1 signaling pathway, thereby reducing glycolytic activity in colorectal cancer under chronic stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesColorectal NeoplasmsGlycolysisReceptors, Adrenergic, beta-2Cyclic AMP Response Element-Binding ProteinStress, PsychologicalAntineoplastic Agents, PhytogenicAnimalsSignal TransductionHumansMaleMiceMice, NudeCell Line, TumorMice, Inbred BALB CXenograft Model Antitumor Assays

Stichwörter der Autor:innen

G-Rb1chronic stresscolorectal cancerglycolysisβ2-AR/CREB1 pathway

Substanzen

Ginsenosidesginsenoside Rb1Receptors, Adrenergic, beta-2Cyclic AMP Response Element-Binding ProteinAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID-Profile: Yun-Feng Guan, Yan Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yao, W., Hua, D. M., Wang, W. K., Zhang, Z. Z., Guan, Y. F., & Wang, Y. (2025). Ginsenoside Rb1 inhibits chronic stress-induced colorectal cancer via regulating glycolysis and β2-AR/CREB1 signaling pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf031

Vancouver

Yao W, Hua DM, Wang WK, Zhang ZZ, Guan YF, Wang Y. Ginsenoside Rb1 inhibits chronic stress-induced colorectal cancer via regulating glycolysis and β2-AR/CREB1 signaling pathway. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf031

BibTeX
@article{Yao2025,
  author = {Yao, Wang and Hua, Dong-Ming and Wang, Wen-Kai and Zhang, Zhao-Zhou and Guan, Yun-Feng and Wang, Yan},
  title = {Ginsenoside Rb1 inhibits chronic stress-induced colorectal cancer via regulating glycolysis and β2-AR/CREB1 signaling pathway},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgaf031}
}
Kostenlos starten →